Guangdong Marubi Biotechnology Co., Ltd.

SHSE:603983 Stock Report

Market Cap: CN¥11.2b

Guangdong Marubi Biotechnology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Huaiqing Sun

Chief executive officer

CN¥2.1m

Total compensation

CEO salary percentagen/a
CEO tenure12.8yrs
CEO ownership72.7%
Management average tenureno data
Board average tenure4.5yrs

Recent management updates

Recent updates

Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?

Nov 22
Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?

Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Sep 26
Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Aug 30
Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Jun 19
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

May 29
Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

May 07
Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Mar 27
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

Feb 29
Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

CEO

Huaiqing Sun (54 yo)

12.8yrs

Tenure

CN¥2,109,000

Compensation

Mr. Huaiqing Sun is Chairman and Chief Executive Officer of Guangdong Marubi Biotechnology Co., Ltd. from January 18, 2012.


Board Members

NamePositionTenureCompensationOwnership
Huaiqing Sun
Chairman & CEO12.8yrsCN¥2.11m72.72%
CN¥ 8.1b
Kaihui Wang
Director & CFOno dataCN¥2.31mno data
Lingchun Zeng
Chief Marketing Officer & Director6.5yrsCN¥2.08mno data
Yong Cao
Independent Director1.5yrsCN¥58.30kno data
Yi Shen
Director3.7yrsCN¥1.04mno data
Chaowan Guo
Director3.7yrsCN¥832.00kno data
Yalin Bi
Independent Director6.5yrsCN¥100.00kno data
Ka Yeung Chan
Supervisor4.9yrsno datano data
Qingmei Chen
Chairman of the the Supervisory Board4yrsno datano data

4.5yrs

Average Tenure

46yo

Average Age

Experienced Board: 603983's board of directors are considered experienced (4.5 years average tenure).